Clinical practice guidelines for therapeutic drug monitoring of arbekacin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring-Reference-Cited by-同舟云学术

Clinical practice guidelines for therapeutic drug monitoring of arbekacin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

Published:2014-01 Issue:1 Volume:20 Page:1-5
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Okada Kenji,Kimura Toshimi,Mikamo Hiroshige,Kasahara Kei,Seki Masafumi,Takakura Shunji,Tokimatsu Issei,Ohmagari Norio,Takahashi Yoshiko,Matsumoto Kazuaki,Igarashi Masahiro,Kobayashi Masahiro,Hamada Yukihiro,Mochizuki Takahiro,Kimura Masao,Nishi Yoshifumi,Tanigawara Yusuke,Takesue Yoshio

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference29 articles.

1. Syntheses of 1-n-((S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3′,4′-dideoxykanamycin B active against kanamycin-resistant bacteria;Kondo;J Antibiot,1973

2. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin;Aoki;Jpn J Antibiot,1994

3. Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus;Hamilton-Miller;J Antimicrob Chemother,1995

4. Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus;Sato;Antimicrob Agents Chemother,2006

5. The therapeutic monitoring of antimicrobial agents;Begg;Br J Clin Pharmacol,2001

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Status and Quality of Guidelines for Therapeutic Drug Monitoring Based on AGREE II Instrument;Clinical Pharmacokinetics;2023-07-25

2. A study of trends and factors associated with therapeutic drug monitoring (TDM) implementation for arbekacin treatment using a large Japanese medical claims database;Journal of Infection and Chemotherapy;2022-09

3. Target Therapeutic Ranges of Anti-MRSA Drugs, Linezolid, Tedizolid and Daptomycin, and the Necessity of TDM;Biological and Pharmaceutical Bulletin;2022-07-01

4. Comparing the pharmacokinetics and organ/tissue distribution of anti-methicillin-resistant Staphylococcus aureus agents using a rat model of sepsis;Xenobiotica;2022-06-03

5. Comparison of In Vivo Transportability of Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents Into Intracellular and Extracellular Tissue Spaces in Rats;Journal of Pharmaceutical Sciences;2021-02